- Our Company
- News & Events
- Contact Us
Guardant Health AMEA (GH AMEA) was pleased to be part of the conference delegation at the 24th Taiwan Joint Cancer Conference (TJCC) in Taipei from 4th to 5th May 2019. TJCC 2019 aimed to provide a platform for experts to share their latest findings from their cancer research as well as their breakthroughs in cancer care. GH AMEA and Genconn ran a booth at the conference to create awareness about the Guardant360® assay and the advantages of using comprehensive liquid biopsies for advanced cancer patients.
The conference, themed Breakthroughs in Cancer Care, was well attended by oncologists and biopharma professionals.